10.3389/fimmu.2019.00829.s008
Maria Zimmermann
Maria
Zimmermann
Natalie Rose
Natalie
Rose
John M. Lindner
John M.
Lindner
Hyein Kim
Hyein
Kim
Ana Rita Gonçalves
Ana Rita
Gonçalves
Ilaria Callegari
Ilaria
Callegari
Mohammedyaseen Syedbasha
Mohammedyaseen
Syedbasha
Lukas Kaufmann
Lukas
Kaufmann
Adrian Egli
Adrian
Egli
Raija L. P. Lindberg
Raija
L. P. Lindberg
Ludwig Kappos
Ludwig
Kappos
Elisabetta Traggiai
Elisabetta
Traggiai
Nicholas S. R. Sanderson
Nicholas
S. R. Sanderson
Tobias Derfuss
Tobias
Derfuss
Data_Sheet_8_Antigen Extraction and B Cell Activation Enable Identification of Rare Membrane Antigen Specific Human B Cells.PDF
Frontiers
2019
autoimmunity
membrane protein antigens
trogocytosis
human monoclonal antibodies
myasthenia gravis
2019-04-16 04:46:26
Dataset
https://frontiersin.figshare.com/articles/dataset/Data_Sheet_8_Antigen_Extraction_and_B_Cell_Activation_Enable_Identification_of_Rare_Membrane_Antigen_Specific_Human_B_Cells_PDF/7997600
<p>Determining antigen specificity is vital for understanding B cell biology and for producing human monoclonal antibodies. We describe here a powerful method for identifying B cells that recognize membrane antigens expressed on cells. The technique depends on two characteristics of the interaction between a B cell and an antigen-expressing cell: antigen-receptor-mediated extraction of antigen from the membrane of the target cell, and B cell activation. We developed the method using influenza hemagglutinin as a model viral membrane antigen, and tested it using acetylcholine receptor (AChR) as a model membrane autoantigen. The technique involves co-culturing B cells with adherent, bioorthogonally labeled cells expressing GFP-tagged antigen, and sorting GFP-capturing, newly activated B cells. Hemagglutinin-specific B cells isolated this way from vaccinated human donors expressed elevated CD20, CD27, CD71, and CD11c, and reduced CD21, and their secreted antibodies blocked hemagglutination and neutralized viral infection. Antibodies cloned from AChR-capturing B cells derived from patients with myasthenia gravis bound specifically to the receptor on cell membrane. The approach is sensitive enough to detect antigen-specific B cells at steady state, and can be adapted for any membrane antigen.</p>